Efficacy of vitamin D-3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

Joost Smolders, Raymond Hupperts, Frederik Barkhof, Luigi M. E. Grimaldi, Trygve Holmoy, Joep Killestein, Peter Rieckmann, Myriam Schluep, Reinhold Vieth, Ulrike Hostalek, Lizette Ghazi-Visser, Manolo Beelke

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)44-49
JournalJournal of the Neurological Sciences
Volume311
Issue number1-2
DOIs
Publication statusPublished - 15 Dec 2011

Keywords

  • Multiple sclerosis
  • Vitamin D
  • Interferon beta-1a
  • 25-Hydroxyvitamin D
  • 1,25-Dihydroxyvitamin D
  • Clinical trial
  • Biomarker
  • SOLAR

Cite this